BRISTOL, Tenn., Oct. 24 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) reported today that the Company plans to announce financial
results for the third quarter ending September 30, 2005 prior to the market
open on Wednesday, November 9, 2005. Conference call information will be
provided when available via a subsequent press release.
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated date for release of the
Company's financial results for the third quarter ending September 30, 2005.
These forward-looking statements involve certain significant risks and
uncertainties, and actual results may differ materially from the forward-
looking statements. An important factor which may cause results to differ is
whether King is able to release the Company's financial results for third
quarter ending September 30, 2005 as currently planned. King does not
undertake to publicly update or revise any of its forward-looking statements
even if experience or future changes show that the indicated results or events
will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
Company News On-Call:
http://www.prnewswire.com/comp/120319.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs, +1-423-989-8125, or David E. Robinson, Senior
Director, Corporate Affairs, +1-423-989-7045, both of King
Pharmaceuticals
|
